Opko Health
OPK
233 hedge funds and large institutions have $776M invested in Opko Health in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 59 increasing their positions, 71 reducing their positions, and 39 closing their positions.
107% more call options, than puts
Call options by funds: $27.1M | Put options by funds: $13.1M
0.06% more ownership
Funds ownership: 28.43% → 28.5% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less capital invested
Capital invested by funds: $816M → $776M (-$40.4M)
3% less funds holding
Funds holding: 239 → 233 (-6)
13% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 39
17% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 71
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$6.05M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.84M |
| 3 |
Renaissance Technologies
New York
|
+$4.86M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$2.84M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$2.81M |
Top Sellers
| 1 |
BlackRock
New York
|
-$12.9M |
| 2 |
D.E. Shaw & Co
New York
|
-$3.84M |
| 3 |
California Public Employees Retirement System
Sacramento,
California
|
-$3.48M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.83M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$2.54M |
OPK Hedge Fund Activity: Q2 2021 in Review
233 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2021, worth a combined $776M — down 4.9% from $816M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of OPK and 34 opened new positions — a net loss of 5 holders — while 71 trimmed existing stakes and 59 added.
The largest buyer was Goldman Sachs, adding an estimated $6.05M. The largest seller was BlackRock, cutting an estimated $12.9M.
- 233 institutional investors held Opko Health (OPK) as of Q2 2021, down from 239 in Q1 2021.
- Funds reported $776M of Opko Health stock for Q2 2021, down 4.9% quarter-over-quarter.
- 34 funds opened new Opko Health positions in Q2 2021 and 39 closed out, a net change of -5 holders.
- The largest Opko Health buyer in Q2 2021 was Goldman Sachs, an estimated $6.05M added.
- The largest Opko Health seller in Q2 2021 was BlackRock, an estimated $12.9M sold.
Based on aggregated 13F filings for Q2 2021.